Pharmacologic Treatments in Acute Respiratory Failure
Authors:
- 29 December 2023
- journal article
- research article
- Published by Elsevier in Critical Care Clinics
- Vol. 40 (2) , 275-289
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (W81XWH2010432)
- National Institutes of Health (T32-HL098054)
- National Institutes of Health (R01-HL155159)
- National Institutes of Health (U01-HL168419)
This publication has 81 references indexed in Scilit:
- A practical guide to the monitoring and management of the complications of systemic corticosteroid therapyAllergy, Asthma & Clinical Immunology, 2013
- Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trialThe Lancet, 2012
- Randomized, Placebo-controlled Clinical Trial of an Aerosolized β2-Agonist for Treatment of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome*Critical Care Medicine, 2006
- Efficacy and Safety of Corticosteroids for Persistent Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2006
- Higher versus Lower Positive End-Expiratory Pressures in Patients with the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2004
- Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome*Critical Care Medicine, 2004
- Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Effects of inhaled nitric oxide in patients with acute respiratory distress syndromeCritical Care Medicine, 1998
- High-Dose Corticosteroids in Patients with the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1987